Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities

Show other versions (1)

OBJECTIVE To estimate rates of prostate-specific antigen (PSA) testing in UK general practices by age, deprivation index and geographical location. SUBJECTS AND METHODS Practice-based, retrospective data on PSA testing patterns in 2007 were collected from a random sample of 87 general practices usin...

Full description

Bibliographic Details
Main Authors:	Williams, N, Hughes, L, Turner, E, Donovan, J, Hamdy, F, Neal, D, Martin, R, Metcalfe, C
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
by: Williams, N, et al.
Published: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
by: Young, GJ, et al.
Published: (2017)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
by: Down, L, et al.
Published: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
by: Down, L, et al.
Published: (2011)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
by: Brindle, L, et al.
Published: (2006)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
by: Avery, K, et al.
Published: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
by: Avery, K, et al.
Published: (2012)

Screening for prostate cancer remains controversial.
by: Neal, D, et al.
Published: (2009)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
by: Moore, A, et al.
Published: (2009)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
by: Macefield, R, et al.
Published: (2009)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
by: Simpkin, A, et al.
Published: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
by: Avery, K, et al.
Published: (2008)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
by: Harrison, S, et al.
Published: (2020)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
by: Burton, A, et al.
Published: (2011)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
by: Collin, S, et al.
Published: (2010)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
by: Lane, J, et al.
Published: (2010)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
by: Harrison, S, et al.
Published: (2016)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
by: Collin, S, et al.
Published: (2009)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
by: Hamdy, F, et al.
Published: (2006)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
by: Tilling, K, et al.
Published: (2010)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
by: Hamdy, F, et al.
Published: (2006)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
by: Vickers, A, et al.
Published: (2010)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
by: Collin, S, et al.
Published: (2009)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
by: Turner, E, et al.
Published: (2011)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
by: Oliver, SE, et al.
Published: (2004)

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City
by: Jalil Ibrahim Salih, et al.
Published: (2013-08-01)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
by: Neal, D, et al.
Published: (2006)

First report of prostate-specific membrane antigen-targeted immunotherapy in prostate cancer: the future is bright
by: Lamb, A, et al.
Published: (2018)

Screening for prostate cancer. The case against.
by: Donovan, J, et al.
Published: (2005)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
by: Mahyar Ghafoori, et al.
Published: (2009-08-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

10-year outcomes in localized prostate cancer.
by: Hamdy, F, et al.
Published: (2017)

Biology of prostate-specific antigen
by: Lilja, H
Published: (2003)

Biology of prostate-specific antigen.
by: Lilja, H
Published: (2003)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
by: Littlejohns, T, et al.
Published: (2016)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)